4//SEC Filing
Epstein David M. 4
Accession 0001415889-22-001517
CIK 0001701541other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:19 PM ET
Size
5.5 KB
Accession
0001415889-22-001517
Insider Transaction Report
Form 4
Epstein David M.
DirectorSee Remarks
Transactions
- Award
Stock Option (Right to Buy)
2022-02-15+300,000→ 300,000 totalExercise: $3.79Exp: 2032-02-14→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on February 15, 2023, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001488668
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:19 PM ET
- Size
- 5.5 KB